What is the risk of spinal hematoma associated with spinal anesthesia?

Risk of Spinal Hematoma with Spinal Anesthesia

The risk of spinal hematoma after spinal anesthesia is extremely low in the general population, estimated at 27 per one million patients (0.0027%), with obstetric patients having even lower risk at approximately 1:200,000. 1, 2

Baseline Risk Stratification

The incidence varies significantly by patient population and clinical context:

• General surgical population: 27 per 1,000 (0.85 per 100,000 for vertebral canal hematoma) 1, 2
• Obstetric patients: 1:200,000 (lowest risk group) 3
• Female orthopedic patients: As high as 1:3,600 (highest risk group) 4
• Spinal anesthesia vs epidural: Spinal anesthesia carries significantly lower risk than epidural or combined spinal-epidural (OR 0.15,95% CI 0.08-0.32) 1

Critical Risk Factors

High-Risk Scenarios (Avoid neuraxial anesthesia):

Anticoagulation-related:

• Therapeutic LMWH within 24 hours 2
• Warfarin with INR >1.4 2
• Clopidogrel/prasugrel within 7 days 2
• Ticagrelor within 5 days 2
• Fondaparinux treatment dose (avoid entirely) 2
• Novel oral anticoagulants within specified windows (rivaroxaban treatment: 48h, dabigatran: 48-96h depending on renal function) 2

Hematologic factors:

• Platelets <75 × 10⁹/L in general population 2
• Platelets <50 × 10⁹/L even in ITP/gestational thrombocytopenia 2
• Pre-existing coagulopathy (identified in 14 of 51 reported hematomas) 5

Technical factors:

• Traumatic or difficult needle placement (present in 21 of 51 cases) 5
• Multiple needle passes 6
• Epidural catheter techniques (higher risk than single-shot) 2

Moderate-Risk Scenarios (Proceed with extreme caution, experienced operator only):

• Prophylactic LMWH 6-12 hours prior 2
• Platelets 50-75 × 10⁹/L in ITP/gestational thrombocytopenia 2
• Platelets 75-100 × 10⁹/L in pre-eclampsia 2
• INR 1.4-1.7 2
• Ankylosing spondylitis (newly identified risk factor) 5

Safe Scenarios (Normal risk):

• Aspirin and NSAIDs: No additional precautions needed 2, 6
• Prophylactic LMWH >12 hours prior 2
• UFH prophylaxis >4 hours with normal APTT 2
• Platelets >100 × 10⁹/L 2
• INR ≤1.4 2

Critical Clinical Pearls

Antiplatelet therapy paradox: Despite theoretical concerns, a prospective study of 1,000 patients found that preoperative antiplatelet therapy (including aspirin in 193 patients) did not increase hemorrhagic complications with neuraxial anesthesia 6. This is reflected in current guidelines stating aspirin and NSAIDs require no additional precautions 2.

ASRA guideline limitations: Multiple case reports document spinal hematomas occurring despite adherence to ASRA guidelines, particularly in patients on multiple anticoagulants 7. This underscores that guidelines reduce but do not eliminate risk.

Spontaneous hematomas: A substantial proportion of spinal hematomas are spontaneous with no identifiable etiology, occurring across all patient populations 7, 8. Among 259 patients reviewed, 74% were on anticoagulants and 27% on antiplatelets 8.

Timing Considerations for Catheter Removal

The risk at catheter removal is not negligible and requires the same precautions as insertion 2:

• Wait ≥4 hours after catheter removal before administering prophylactic LMWH 2
• Consider extending to 24 hours if placement was traumatic 2
• Maintain vigilance for 90+ days post-procedure 9

Prognostic Factors

Neurological recovery is directly related to pre-surgical neurological deficit 7:

• Patients with less impairment before decompression have higher likelihood of complete recovery
• This relationship exists regardless of time interval between symptom onset and surgery
• Immediate diagnosis and intervention provide the best outcomes 8

Diagnostic Approach

When spinal hematoma is suspected:

• MRI is the gold standard for diagnosis, particularly for anterior spinal cord syndrome presentations 10
• CT may miss early hematomas and should not provide false reassurance 10
• Classic triad: back pain, sensory deficits, motor deficits (though anterior spinal cord syndrome may present atypically with preserved fine touch) 10

Special Populations

Obstetric patients have the lowest risk and more liberal thresholds apply 2:

• Platelets >75 acceptable if stable and no other coagulopathy
• In ITP/gestational thrombocytopenia, experienced operators may proceed with platelets >50 if stable
• Pre-eclampsia requires coagulation screen if platelets <100

Pediatric patients: Hematomas typically spontaneous, related to coagulopathy or athletic trauma rather than procedural 7